Clinical Features of Solitary Fibrous Tumor: Insights From a Single Center Experience
Journal of Surgical Oncology · 2026-05 · 133 (6) · 803-810
DOI: 10.1002/jso.70215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 08.03.2026. Verfasst von Chenglong Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Shengli Oilfield Central Hospital, Dongying City, Shandong, China. Hauptthemen laut MEDLINE: Solitary Fibrous Tumors, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives This study investigates the clinical characteristics, pathological features, immunohistochemical profiles, and prognostic factors of solitary fibrous tumors (SFTs) to provide insights into their management and prognosis.
Methods
A retrospective analysis was conducted on 43 cases of SFTs diagnosed at a single center. Patient demographics, tumor characteristics, immunohistochemical (IHC) markers, and outcomes were collected.
Results
Among the 43 cases, the majority of tumors were infratentorial (81%), and 60% were classified as WHO Grade 1. IHC analyses revealed high expression rates of STAT6 (62.5%), CD34 (82.5%), and Ki‐67 (100%). Ki‐67 demonstrated the strongest correlation with tumor grade and risk scores ( r = 0.62, p < 0.001; r = 0.68, p < 0.001), indicating its role as a significant prognostic marker. CD34 and STAT6 also showed moderate correlations with tumor aggressiveness. Metastatic presentations were noted in 57.5% of cases. The study highlights the heterogeneity of SFTs and the importance of IHC markers in risk stratification.
Conclusion
The findings underscore the utility of IHC markers, particularly Ki‐67, STAT6, and CD34, in assessing the aggressiveness and prognosis of SFTs. Future studies should focus on multicenter validations, integration of advanced molecular diagnostics, and long‐term follow‐up to refine risk models and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Imaging, Shengli Oilfield Central Hospital, Dongying City, Shandong, China.
- Department of Clinical Laboratory, Shengli Oilfield Central Hospital, Dongying City, Shandong, China.
- Department of Pathology, Shengli Oilfield Central Hospital, Dongying City, Shandong, China.
ORCID-Profile: Songbo Zhao
Zitieren
APA
Zhou, C., Zhang, L., Wang, H., Cao, Y., Lan, X., & Zhao, S. (2026). Clinical Features of Solitary Fibrous Tumor: Insights From a Single Center Experience. Journal of Surgical Oncology, 133(6), 803-810. https://doi.org/10.1002/jso.70215
Vancouver
Zhou C, Zhang L, Wang H, Cao Y, Lan X, Zhao S. Clinical Features of Solitary Fibrous Tumor: Insights From a Single Center Experience. Journal of Surgical Oncology. 2026;133(6):803-810. doi:10.1002/jso.70215
BibTeX
@article{Zhou2026,
author = {Zhou, Chenglong and Zhang, Lijuan and Wang, Hui and Cao, Yuwang and Lan, Xiongbin and Zhao, Songbo},
title = {Clinical Features of Solitary Fibrous Tumor: Insights From a Single Center Experience},
journal = {Journal of Surgical Oncology},
year = {2026},
volume = {133},
number = {6},
pages = {803--810},
doi = {10.1002/jso.70215}
}
EUVIMED